Quince Therapeutics, Inc.
Quince Therapeutics develops eDSP, which encapsulates desipramine into patient red blood cells using its AIDE drug/device platform for ataxia-telangiectasia.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 13Latest story
November 2026
October 2026
September 2026
August 2026
July 2026